TP53 and glioblastoma: Consistent with the critical roles of P53 and PTEN-PI3K-AKT alterations in GBM pathogenesis, GBM genomic and proteomic profiles from TCGA show significant correlation between higher levels of AKT activation and worse prognosis in patients with P53 mutations [42].